Composition of the coordinating centre and trial steering committee 
ADVERSE EFFECTS, MINOR
This is a single-centre study. The trial steering committee will consist of the principal investigator (DB), trial coordinator (SL) and personnel responsible for data entry and data management (CF, YOM and DL). This committee will meet monthly to evaluate the progress of the trial, address ongoing organisational and logistical issues and consider any adverse effects. There will be ongoing communication by way of group email for minor or transient needs. More frequent steering committee meetings will be scheduled should the need arise.